Our core mission is to quickly help patients find a treatment that works for them
Who we are…
The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments.
Translational genomics research is a relatively new field employing innovative advances arising from the Human Genome Project and applying them to the development of diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.
What we do…
Since its inception in 2006, the ACC Research Program at TGen has made significant strides toward understanding ACC and its treatment strategies.
The ACC Research Program focuses in three areas: the collection of adrenocortical tumors (both benign and malignant), the molecular characterization of those samples, and validation of new therapeutic options prior to clinical trials.
How we do it…
For the first time in history, we now have the knowledge to unravel the genetic components of common and complex diseases. The increased understanding of molecular medicine is shifting clinical practice from treatment based on symptoms to treatment based on the underlying causes of disease. Physicians will be prescribing drugs that are designed more intelligently, work more effectively, and have fewer toxic side effects.
Clinical Trials
A strategic alliance with Honor HealthHealth Research Institute (HHRI) provides a direct clinical research site for TGen through the Virginia G. Piper Cancer Center (VGPCC) Clinical Trials.
Led by Dr. Daniel Von Hoff, TGen’s Physician-in-Chief, the clinical site offers patients the latest in clinical trial options for ACC.
About the VGPCC Clinical Trials at HHRI
VTGen/VGPCC Clinical Trials clinicians focus on clinical trials with targeted agents and genomics-based individualized therapy. The TGen/VGPCC Clinical Trials, with an initial focus on cancer, allows the unique opportunity for TGen to transition its laboratory-based research to patient care centered on individualized therapy.
Contacts
For all patients inquiring about a particular study, please contact patient care coordinator, Joyce Schaffer.
Joyce Schaffer MSN RN AOCNS | Supervisor, Nurse Navigator | HonorHealth Research Institute
10510 N. 92nd Street | Suite 200 | Scottsdale, AZ 85258
P: 480-323-1339| F: 480-882-5820
